158 related articles for article (PubMed ID: 9540127)
1. Hypertension-induced congestive heart failure.
Hansson L
Scand Cardiovasc J Suppl; 1998; 47():5-7. PubMed ID: 9540127
[TBL] [Abstract][Full Text] [Related]
2. [Prevention and treatment of congestive heart failure in diabetic patients].
Anguita Sánchez M
Rev Esp Cardiol; 2002 Oct; 55(10):1083-7. PubMed ID: 12383394
[TBL] [Abstract][Full Text] [Related]
3. Slowing the progression of heart failure.
Cohn JN
Eur Heart J; 1996 Nov; 17(11):1609-11. PubMed ID: 8922902
[No Abstract] [Full Text] [Related]
4. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
6. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
8. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol in the treatment of elderly patients with chronic heart failure.
Witte KK; Clark AL
Clin Interv Aging; 2008; 3(1):55-70. PubMed ID: 18488879
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
11. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.
Remme WJ;
Cardiovasc Drugs Ther; 2001 Jan; 15(1):69-77. PubMed ID: 11504166
[TBL] [Abstract][Full Text] [Related]
12. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
13. [Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].
Isnard R
Ann Cardiol Angeiol (Paris); 2002 Jan; 51(1):48-50. PubMed ID: 12510669
[No Abstract] [Full Text] [Related]
14. Carvedilol: the new role of beta blockers in congestive heart failure.
Vanderhoff BT; Ruppel HM; Amsterdam PB
Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol in heart failure.
Kelly DT
Cardiology; 1993; 82 Suppl 3():45-9. PubMed ID: 8106165
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group.
Yoshikawa T; Baba A; Suzuki M; Yokozuka H; Okada Y; Nagami K; Takahashi T; Mitamura H; Ogawa S
Am J Cardiol; 2000 Jun; 85(12):1495-7; A7. PubMed ID: 10856401
[No Abstract] [Full Text] [Related]
17. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
18. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
[TBL] [Abstract][Full Text] [Related]
19. Medical resource use and costs of congestive heart failure after carvedilol use.
Najib MM; Goldberg Arnold RJ; Kaniecki DJ; Pettit KG; Roth D; Antell L; Xuan J
Heart Dis; 2002; 4(2):70-7. PubMed ID: 11975837
[TBL] [Abstract][Full Text] [Related]
20. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
